Mandibular Full-arch Rehabilitation With Internal Hexagonal and Conical Connection Implants
1 other identifier
interventional
18
1 country
1
Brief Summary
Nuvo Tapered IF (internal hexagonal connection) and CF (conical connextion) Implants were designed for the the oral functional rehabilitation using dental implants, allowing for treatment of patients with different bone qualities. The aim of the study is to confirm the long-term safety and clinical performance of implants and abutments of Nuvo IF and CF in daily dental practice setting, by means of prospective collection of clinical data in randomized clinical trial using these devices. Devices will be used , according to manufacturer indications in the IFU. Patients will be followed for 36 months after implant loading.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2021
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 15, 2021
CompletedStudy Start
First participant enrolled
September 23, 2021
CompletedFirst Posted
Study publicly available on registry
October 18, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
July 30, 2025
CompletedNovember 13, 2023
November 1, 2023
3.6 years
September 15, 2021
November 8, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Periimplant bone level change
Amount of Periimplant bone level change 36 months after loading.
up to 36 months
Secondary Outcomes (9)
Implant survival rate
up to 36 months
Prosthetic survival
6, 12, 24 and 36 months
Soft tissue evaluation
up to 36 months
Patient satisfaction
up to 36 months
Clinician satisfaction
up to 36 months
- +4 more secondary outcomes
Study Arms (2)
Group IF
OTHERTwo Tapered IF implants will be installed in one side of the mandible
Group CF
OTHERTwo Tapered IF implants will be installed in the other side of the mandible
Interventions
2 IF Tapared Implants (Group IF) on one side of the mandible
2 CF Tapared Implants (Group CF) on the other side of the mandible
Eligibility Criteria
You may qualify if:
- Patients who qualify for mandibular rehabilitation by means of full-arch prostheses supported by two Nuvo Tapered IF implants and two Tapered CF implants
You may not qualify if:
- Contraindications according to the Instructions for Use of the device will be applied, as follows:
- Signs of allergy or hypersensitivity to the chemical ingredients of the material: titanium;
- Presence of acute inflammatory or infectious processes in live tissue;
- Unsuitable bone volume and/or quality;
- Systemic complications or diseases such as: bone metabolism disorders, blood clotting disorders, unsuitable healing capacity, insufficient oral hygiene, incomplete jawbone growth, patient uncooperative and not motivated, abuse of drugs or alcohol, psychosis, prolonged functional disorders which resist any treatment with medications, xerostomia, weakened immunological system, diseases which require the use of steroids, endocrinological diseases, pregnancy.
- The research does not involve minors, or women who are pregnant or breastfeeding.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Neodentlead
Study Sites (1)
Mattias Sartori Consultoria Em Odontologia
Bauru, São Paulo, Brazil
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Waleska Caldas, PhD
Neodent
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 15, 2021
First Posted
October 18, 2021
Study Start
September 23, 2021
Primary Completion
May 1, 2025
Study Completion
July 30, 2025
Last Updated
November 13, 2023
Record last verified: 2023-11
Data Sharing
- IPD Sharing
- Will not share